UnitedHealth Group Incorporated (NYSE:UNH) Stake Boosted by Summit Place Financial Advisors LLC

Summit Place Financial Advisors LLC increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 5.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,162 shares of the healthcare conglomerate’s stock after purchasing an additional 249 shares during the quarter. Summit Place Financial Advisors LLC’s holdings in UnitedHealth Group were worth $2,611,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the stock. Vista Capital Partners Inc. grew its stake in UnitedHealth Group by 19.3% during the 4th quarter. Vista Capital Partners Inc. now owns 737 shares of the healthcare conglomerate’s stock valued at $373,000 after acquiring an additional 119 shares in the last quarter. Hudson Value Partners LLC grew its stake in UnitedHealth Group by 35.3% during the 4th quarter. Hudson Value Partners LLC now owns 1,446 shares of the healthcare conglomerate’s stock valued at $732,000 after acquiring an additional 377 shares in the last quarter. Laidlaw Wealth Management LLC grew its stake in UnitedHealth Group by 1.7% during the 4th quarter. Laidlaw Wealth Management LLC now owns 1,409 shares of the healthcare conglomerate’s stock valued at $713,000 after acquiring an additional 24 shares in the last quarter. Global Retirement Partners LLC lifted its holdings in shares of UnitedHealth Group by 2.0% during the 4th quarter. Global Retirement Partners LLC now owns 19,436 shares of the healthcare conglomerate’s stock valued at $9,832,000 after buying an additional 386 shares during the last quarter. Finally, Semus Wealth Partners LLC lifted its holdings in UnitedHealth Group by 5.3% in the 4th quarter. Semus Wealth Partners LLC now owns 2,423 shares of the healthcare conglomerate’s stock worth $1,226,000 after purchasing an additional 121 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on UNH shares. Truist Financial dropped their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Stephens upped their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Wells Fargo & Company reduced their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Down 4.2 %

Shares of UnitedHealth Group stock opened at $501.52 on Wednesday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The business has a 50-day moving average of $521.08 and a two-hundred day moving average of $562.03. The company has a market capitalization of $461.54 billion, a P/E ratio of 32.36, a price-to-earnings-growth ratio of 1.43 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the firm earned $5.83 EPS. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.